Search

everythinglearnresearchcommunity

for

Search:↓

Abrocitinib is being evaluated for safety and effectiveness in treating moderate to severe atopic dermatitis.

Poor air quality increases the risk of atopic dermatitis in Taiwan.

Atopic diseases worsen alopecia areata, leading to earlier onset and more severe forms.

Adults with alopecia areata stick to their medication better than those with atopic dermatitis.

Combining NB-UVB 311 nm therapy with standard treatment improves hair regrowth in children with alopecia areata and atopic dermatitis.

Allergen-specific immunotherapy can significantly improve hair loss and dermatitis symptoms in severe cases.

Platelet-rich plasma treatment may safely and effectively reduce skin lesions in psoriasis and atopic dermatitis.

Neutrophils are important for causing chronic itch in atopic dermatitis, and blocking the CXCR3 receptor may reduce this itch.

Dupilumab is effective and safe for treating moderate-to-severe atopic dermatitis in adolescents.

Sodium hypochlorite can effectively prevent and remove Staphylococcus aureus biofilms in atopic dermatitis at high enough concentrations.

Mineral levels in hair don't significantly affect the severity of atopic dermatitis in children.

LEKTI is crucial for skin barrier and immune function, affecting conditions like Netherton syndrome and atopic dermatitis.

A child with rough nails also had hair loss and allergies.

Upadacitinib effectively treated severe atopic dermatitis, vitiligo, and alopecia areata in one patient.

JAK inhibitors show promise in treating skin conditions like eczema, hair loss, and vitiligo but need more safety research.

Atopic dermatitis affects the appearance of skin reactions, making certain features more common and improving diagnostic accuracy with dermoscopy.

Alopecia areata and atopic dermatitis share immune system issues, and treatments like JAK inhibitors can help both.

A specific group of immune and skin cells may cause chronic inflammation in atopic dermatitis.

Tralokinumab for atopic dermatitis may cause eye issues and skin reactions, needing careful monitoring.

Bifidobacterium animalis subsp. lactis J12 helps reduce atopic dermatitis symptoms.

Adipocytes in atopic dermatitis skin change and worsen inflammation and fibrosis.

Dupilumab effectively treats severe skin issues in a rare genetic disorder.

Upadacitinib improved symptoms and hair regrowth in a teen with multiple autoimmune conditions.

Staphylococcus aureus affects immune responses and skin cells in atopic dermatitis, suggesting new treatment targets.

Certain immune cells in atopic dermatitis skin could be targeted for treatment.

Nemolizumab improved both severe atopic dermatitis and alopecia areata in one patient.

JAK1 inhibitors can help reduce itchiness in atopic dermatitis.

People often have negative attitudes towards facial skin conditions, with vitiligo seen most positively and psoriasis viewed most negatively.

Oral tofacitinib successfully treated a girl's severe skin and hair conditions.

Recognizing and treating related skin conditions can improve atopic dermatitis management.